Mereo BioPharma Group Plc (MREO)

0.2992 -0.01 (-1.90%) USD  |  NASDAQ  |  Jun 09, 16:00
0.2982 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group SG&A Expense (Quarterly) : 4.012M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
NuCana Plc 2.113M
Biodexa Pharmaceuticals Plc --
Silence Therapeutics Plc 7.026M
BioNTech SE 176.43M
Compass Pathways Plc 16.40M